A detailed history of Boston Partners transactions in Mednax, Inc. stock. As of the latest transaction made, Boston Partners holds 1,562,753 shares of MD stock, worth $22.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,562,753
Previous 1,691,700 7.62%
Holding current value
$22.6 Million
Previous $12.8 Million 41.93%
% of portfolio
0.02%
Previous 0.02%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$6.77 - $11.6 $872,971 - $1.5 Million
-128,947 Reduced 7.62%
1,562,753 $18.1 Million
Q2 2024

Aug 13, 2024

SELL
$6.77 - $9.74 $641,349 - $922,709
-94,734 Reduced 5.3%
1,691,700 $12.8 Million
Q1 2024

May 13, 2024

BUY
$8.46 - $10.03 $3.83 Million - $4.55 Million
453,254 Added 34.0%
1,786,434 $17.9 Million
Q4 2023

Feb 07, 2024

BUY
$8.38 - $12.98 $11.2 Million - $17.3 Million
1,333,180 New
1,333,180 $12.4 Million
Q2 2022

Aug 10, 2022

SELL
$17.53 - $24.32 $204,750 - $284,057
-11,680 Reduced 52.63%
10,514 $221,000
Q1 2022

May 10, 2022

BUY
$22.38 - $27.7 $208,380 - $257,914
9,311 Added 72.27%
22,194 $521,000
Q4 2021

Feb 04, 2022

BUY
$24.43 - $28.72 $314,731 - $369,999
12,883 New
12,883 $351,000

Others Institutions Holding MD

About MEDNAX, INC.


  • Ticker MD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 84,353,504
  • Market Cap $1.22B
  • Description
  • Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals thr...
More about MD
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.